期刊文献+

甲基丙二酸血症患者血串联质谱及尿气相色谱质谱检测分析 被引量:20

Analysis of propinoylcarnitine in blood and methylmalonic acid in urine of 162 patients withmethylmalonic acidemia
原文传递
导出
摘要 目的探讨甲基丙二酸血症(MMA)患者尿甲基丙二酸、甲基枸橼酸水平及血丙酰肉碱(C3)水平、丙酰肉碱与乙酰肉碱的比值(C3/C2)的变化及其在MMA诊断中的应用价值。方法分析2003年12月至2012年3月上海交通大学附属新华医院确诊的162例MMA患者及200名健康儿童(对照组)尿甲基丙二酸、甲基枸橼酸及血C3水平、C3/C2变化,已明确分型的患者分为单纯型MMA组(n=51)和MMA合并同型半胱氨酸血症组(合并型MMA组)(n=65);尿甲基丙二酸及甲基枸橼酸水平采用气相色谱质谱检测,血C2、C3及蛋氨酸(Met)水平采用串联质谱技术检测。结果MMA患者尿甲基丙二酸和甲基枸橼酸水平分别为259.10(6.73~6429.28)和4.39(0~248.96),血C3和C3/C2中位数(范围)分别为8.52(1.50~52.11)μmol/L和0.73(0.28~2.89),均高于参考值(分别为0.2~3.6、0~1.1、0.50~4.00μmol/L、0.04~0.25),且显著高于对照组[分别为0(0~1.87)、0.10(0~1.84),1.40(0.53~3.90)p.mol/L、0.10(0.04~0.23),均P〈0.01]。其中15例患者血c3水平正常,而C3/C2及尿甲基丙二酸水平均增高。合并型MMA组血蛋氨酸水平低于参考值和单纯型MMA患者组及对照组[8.71(0.68~31.95)μmol/L比10.00~35.00μmol/L、15.35(4.18~59.50)μmol/L、15.59(10.20~34.68)μmol/L,均P〈0.05]。结论尿甲基丙二酸及血C3/C2显著增高对诊断MMA具有特异性,诊断MMA需将两种检测方法结合以减少漏诊及误诊。尿甲基丙二酸及血C3/C2轻度增高者需反复送检或基因检测确诊。 Objective To analyze the levels of methylmalonic acid and methylcitric acid in urine, propinoylcarnitine (C3) in plasma and C3/acetylcarnitine (C2) of patients with methylmalonie acidemia (MMA) and explore their applications in the diagnosis of MMA. Methods From December 2003 to March 2012, a total of 162 patients with MMA (MMA group) and 200 healthy children (control group) of Xinhua Hospital, Shanghai Jiaotong University School of Medicine were recruited. MMA patients with a definite classification were divided into 2 groups: isolate MMA group ( n = 51 ) and MMA complicated with homocysteinemia group ( n = 65 ). Gas chromatography-mass spectrometry was used to measure the urine levels of methylmalonic acid and methylcitric acid and tandem mass spectrometry to measure the blood levels of free carnitine (C0) , acylcamitines and methionine (Met). Results In the MMA group, the median levels of methylmalonic acid ( 259. 10 ( 6. 73 - 6429. 28 ) ), methylcitric acid ( 4. 39 ( 0 - 248.96 ) ), C3 ( 8. 52 ( 1.50 - 52. 11 ) μmol/L) and C3/C2 ( 0. 73 ( 0. 28 - 2. 89 ) ) were all higher than the upper limit values(0. 2 -3.6, 0 - 1.1,0. 50 -4. 00 μmo]/L and 0. 04 -0. 25 respectively). And they were all higher than those in the control group (0 (0 - 1.87), 0. 10 (0 - 1.84), 1.40 (0. 53 - 3.90)μmo]/L, 0. 10 (0. 04-0. 23), all P 〈0. 01). C3/C2 increased significantly in 15 patients while the C3 level remainednormal. The median level of Met was normal in the isolate MMA group. But in patients with homocysteinemia, the level of 8.71 (0. 68 -31.95 )μmol/L was below the reference value (10. 00 - 35.00 μmol/L) and lower than that in the isolate MMA group( 15.35 (4. 18 -59.50)μmol/L)and the control group(15.59(10.20-34.68) μmol/L, all P〈0.05). Conclusions Significant increases in the urine level of methylmalonic acid and C3/C2 may be specific to MMA. Organic acid analyses of gas chromatography-mass spectrometry and acylcarnitines with tandem mass spectrometry are required for a definite diagnosis of this disorder. And repeated tests and genomic mutation analysis are necessary for patients with mildly abnormal biochemical indices.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第8期561-565,共5页 National Medical Journal of China
基金 国家863高技术研究发展计划(2007AA022447) 上海市卫生局重大课题(2008ZD001) 上海市卫生局科研课题(2009210) 上海市科委重大课题(11dz1950300)
关键词 甲基丙二酸 串联质谱法 气相色谱-质谱法 丙酰肉碱 Methylmalonic acid Tandem mass spectrometry Gas chromatography-mass spectrometry Propinoylcarnitine
  • 相关文献

参考文献21

  • 1Fenton W A, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism! IScriver CR, Beaudet AL, Sly WS, et al. The metabolic and molecular basis of inherited disease. 8th ed. New York: McGraw-Hill, 2001: 2165-2193.
  • 2Horster F, Hoffmann GF. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria-recent advances and new challenges. Pediatr Nephrol , 2004,19:1071-1074.
  • 3Shigematsu Y, Hata I, Tajima G. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduriaJ Inherit Metab Dis, 2010, 33 Suppl 2: S283-S288.
  • 4罗小平,王慕逖,魏虹,梁雁,王宏伟,林汉华,董永绥,刘皖君,方俊敏,宁琴.尿滤纸片法气相色谱-质谱分析技术在遗传性代谢病高危筛查诊断中的应用[J].中华儿科杂志,2003,41(4):245-248. 被引量:115
  • 5顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 6韩连书,叶军,邱文娟,高晓岚,王瑜,金晶,顾学范.串联质谱联合气相色谱-质谱检测遗传性代谢病[J].中华医学杂志,2008,88(30):2122-2126. 被引量:60
  • 7de Baulny HO, BenoistJF, Rigal 0, et al. Methylmalonic and propionic acidaemias , management and outcome.J Inherit Metab Dis, 2005, 28 :415423.
  • 8Deodato F, Boenzi S, Santorelli FM, et al. Methylmalonic and propionic aciduria AmJ Med Genet C Semin Med Genet, 2006, 142C: 104-112.
  • 9Han LS, YeJ, Qiu WJ, et al. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.J Inherit Metab Dis, 2007, 30 :507 -514.
  • 10Van Gosen L. Organic acidemias , a methylmalonic and propionic focus.J Pediatr Nurs , 2008, 23 :225-233.

二级参考文献53

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱分析干血滤纸片酰基肉碱方法的建立[J].中华检验医学杂志,2005,28(1):88-91. 被引量:31
  • 3韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱技术在有机酸血症筛查中的应用研究[J].中华儿科杂志,2005,43(5):325-330. 被引量:62
  • 4宁聪 方红 熊密.二羧酸尿症一例[J].中华儿科杂志,1990,28:303-303.
  • 5Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem, 2001, 47: 1945 -1955.
  • 6Chace DH, Kales TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem, 2005, 38 : 296-309.
  • 7Garg U, Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspect. Clin Biochem, 2006, 39 : 315 -332.
  • 8Frazier DM, Millington DS, McCandless SE, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis, 2006, 29: 76-85.
  • 9Schulze A, Lindner M, KohlmuUer D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics, 2003,111: 1399-1406.
  • 10Yoon HR, Lee Kit, Kang S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Claim Acta, 2005, 354:167-180.

共引文献275

同被引文献129

引证文献20

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部